Immunovant Cash Flow Statement (2018-2026) | IMVT

Cash Flow Statement Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-30.47M-37.70M-41.38M-47.17M-40.37M-47.93M-63.23M-59.43M-73.94M-58.66M-51.42M-75.32M-87.15M-109.12M-111.12M-106.45M-120.61M-126.50M-110.64M-147.84M
Depreciation and Depletion (Quarter)
0.03M0.03M0.03M0.04M0.04M0.05M0.05M0.05M0.05M0.06M0.06M0.06M0.08M0.09M0.10M0.11M0.11M0.10M0.10M0.10M
Share-based Compensation (Quarter)
3.86M8.36M10.16M-22.25M7.69M8.16M8.91M7.55M10.69M10.53M10.22M-31.35M13.46M12.69M-26.15M0.10M18.51M13.36M12.71M-44.51M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)
-21.21M-20.05M-31.89M-32.96M-65.82M-20.19M-46.40M-55.79M-47.37M-60.06M-47.10M-59.70M-76.20M-88.65M-100.39M-110.64M-117.41M-102.52M-92.33M-95.06M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.27M0.28M0.28M0.28M0.28M0.28M0.28M0.29M0.29M0.29M0.29M0.25M0.07M0.02M0.02M0.02M0.02M0.02M0.03M0.03M
Depreciation & Amortization (CF) (Quarter)
0.03M0.03M0.03M0.04M0.04M0.05M0.05M0.05M0.05M0.06M0.06M0.06M0.08M0.09M0.10M0.11M0.11M0.10M0.10M0.10M
Change in Working Capital
Change in Receivables (Quarter)
0.21M0.18M7.53M3.71M0.95M-9.76M-2.94M-0.00M0.14M0.56M-0.27M4.14M-2.93M-0.42M0.20M-0.09M-0.13M0.03M-0.32M-0.56M
Change in Account Payables (Quarter)
0.68M1.14M-0.43M14.87M-17.48M6.52M6.47M4.65M25.01M-18.91M-3.70M3.39M3.88M9.37M-0.26M-2.30M-9.40M-1.06M1.56M-1.35M
Change in Accured Expenses (Quarter)
1.17M6.73M8.29M-6.72M-5.54M4.18M2.63M14.29M-17.29M8.53M-5.34M15.46M-7.54M10.67M4.15M1.65M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-0.36M
Investing Activities
Capital Expenditures (Quarter)
0.02M0.04M0.07M0.12M0.04M0.03M0.10M0.03M0.04M-0.04M0.36M0.18M7.89M-7.51M7.18M-0.07M
Cash from Investing Activities (Quarter)
-0.02M-0.04M-0.07M-0.12M-0.04M-0.03M-0.10M-0.03M-0.04M-0.03M-0.13M-0.15M-0.18M-0.20M-0.18M-0.20M-0.01M
Financing Activities
Other financing activities (Quarter)
0.13M0.02M0.40M0.23M0.89M0.15M3.11M1.54M0.69M0.73M2.46M0.93M2.92M24.59M21.00M3.56M
Cash from Financing Activities (Quarter)
0.09M200.04M0.02M70.63M0.23M0.89M0.15M469.84M1.54M0.69M0.73M2.46M450.61M2.92M24.59M564.60M3.64M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
200.00M70.50M450.00M
Additional items
Exchange Rate Effect (Quarter)
0.02M-0.11M-0.77M-1.22M2.70M-0.49M-0.05M-0.09M-1.61M2.73M0.34M1.05M-0.15M-0.49M-0.57M0.88M0.38M-0.99M
Change in Cash (Quarter)
-21.14M179.95M-31.95M-33.19M-66.61M-21.43M26.84M-56.08M-46.57M-60.03M421.01M-55.57M-75.36M-87.06M-98.26M339.29M-115.06M-77.04M472.65M-92.42M
Free Cash Flow (Quarter)
-21.23M-20.09M-31.97M-33.07M-65.86M-20.22M-46.49M-55.82M-47.41M-60.02M-47.10M-60.06M-76.38M-96.54M-92.88M-117.81M-117.41M-102.52M-92.33M-94.99M
Net Cash Flow (Quarter)
-21.14M179.95M-31.97M-33.07M-65.84M-20.22M24.14M-55.59M-46.52M-59.95M422.62M-58.30M-75.69M-88.11M-98.11M339.77M-114.49M-77.92M472.28M-91.43M